New FDA-Approved Blood Test Could Detect Alzheimer’s 5 to 10 Years Before Symptoms Appear

Atthapon Raksthaput
Paired with new FDA-approved treatments and evidence-backed lifestyle modifications that slow disease progression, the arrival of simple blood testing shifts Alzheimer’s from an untreatable fate to a manageable condition.

By detecting the subtle brain changes and damage to nerve cells years before memory or language issues surface, the blood test allows patients to seek treatment during the window when therapies are most effective.

Read original article